United States · Series B startup

Who invested in Mirador Therapeutics

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$250Mraised across 1 round since 2026, from 1 source

Latest round
Series B, $250MJan 2026
Investors
7
See who backed them

The rounds

  1. Jan 2026
    Series B$250M

    Source recorded

Founders and team

From Mirador Therapeutics's own website and the SEC filings it signed: 1 founder, 9 on the team.

Mark C. McKennaFounder, Chairman & CEONamed on its 2024 Form D
  • Maulik ShahChief Financial Officer
  • Nori EbersoleChief People Officer
  • Tim AndrewsChief Legal Officer
  • Vika K. BroughChief Accounting Officer
  • Strategic AdvisorBoard of Directors
  • Joseph K. PapaDirector
  • Kristina K. BurowDirector
  • Paul K. BernsDirector
  • Timothy K. AndrewsExecutive Officeri

On the board, as filediDavid K. BonitaScott K. Glenn

Everyone who backed them

FidelityVC firm1round
ARCH Venture PartnersVC firm1round
TCGPrivate equity1round
SanofiInvestment firm1round
RTW Investments LLCGrowth equity1round
TCG CrossoverVC firm1round
Blue OwlAsset manager1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Mirador Therapeutics

Who invested in Mirador Therapeutics?

Mirador Therapeutics's investors include Fidelity, ARCH Venture Partners, TCG, Sanofi and RTW Investments LLC, and 2 more on record.

How much has Mirador Therapeutics raised?

Mirador Therapeutics has raised $250M across 1 round since 2026.

When did Mirador Therapeutics last raise?

Mirador Therapeutics's most recent round was a Series B of $250M in Jan 2026.

What was Mirador Therapeutics's biggest round?

Its most recent round, $250M in Jan 2026, is also its largest on record.

Who backed Mirador Therapeutics first?

Mirador Therapeutics's first round on record, in Jan 2026, was backed by Fidelity, ARCH Venture Partners and TCG and 4 others.

What stage is Mirador Therapeutics at?

Mirador Therapeutics's latest named round is a Series B, in Jan 2026.

Where is Mirador Therapeutics based?

Mirador Therapeutics is based in the United States.

Companies like Mirador Therapeutics

In the same sector, and raised in the last eighteen months.

Star Therapeutics$325M · Oct 2026Promaxo$106M · Oct 2026Prolific Machines$105M · Oct 2026IMIO$19M · Oct 2026Clinical Ink$24M · Oct 2026Rejuvenate Bio$13M · Oct 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app